Literature DB >> 24639430

[Colorectal cancer - review].

Sigurdis Haraldsdottir, Hulda M Einarsdottir, Agnes Smaradottir, Adalsteinn Gunnlaugsson, Thorvardur R Halfdanarson.   

Abstract

Colorectal cancer is the third most common cancer in the Western hemisphere and the incidence increases with increasing age. Most colorectal cancers are localized with or without lymph node metastases. Up to 20% of patients present with metastatic disease, most commonly to the liver. Surgery is the only curative therapy for localized colorectal cancer and adjuvant chemotherapy is usually recommended for patients with lymph node metastases. Surgery, radiation therapy and chemotherapy are the key components of rectal cancer therapy. Selected patients with recurrent and metastatic disease can be salvaged with surgery but chemotherapy remains the mainstay of therapy for advanced colorectal cancer. Substantial progress has been observed in the treatment of metastatic colorectal cancer in recent years.

Entities:  

Mesh:

Year:  2014        PMID: 24639430     DOI: 10.17992/lbl.2014.02.531

Source DB:  PubMed          Journal:  Laeknabladid        ISSN: 0023-7213            Impact factor:   0.548


  35 in total

Review 1.  Cardiovascular complications of metastatic colorectal cancer treatment.

Authors:  Kalliopi Keramida; Georgios Charalampopoulos; Dimitrios Filippiadis; Elias Tsougos; Dimitrios Farmakis
Journal:  J Gastrointest Oncol       Date:  2019-08

Review 2.  Targeting E-cadherin expression with small molecules for digestive cancer treatment.

Authors:  Yizuo Song; Miaomiao Ye; Junhan Zhou; Zhiwei Wang; Xueqiong Zhu
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

3.  Health-related quality of life among patients with colorectal cancer.

Authors:  Loai Abu Sharour; Omar Al Omari; Ayman Bani Salameh; Dalal Yehia
Journal:  J Res Nurs       Date:  2019-08-22

4.  Evaluation and Prediction Analysis of 3- and 5-Year Survival Rates of Patients with Cecal Adenocarcinoma Based on Period Analysis.

Authors:  Zi'an Shao; Shuai Zheng; Chong Chen; Jun Lyu
Journal:  Int J Gen Med       Date:  2021-10-28

5.  High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD).

Authors:  Lizong Wang; Yi Cao; Wei Guo; Jingyun Xu
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-29       Impact factor: 4.322

Review 6.  Chemical Compounds of Berry-Derived Polyphenols and Their Effects on Gut Microbiota, Inflammation, and Cancer.

Authors:  Abdelhakim Bouyahya; Nasreddine El Omari; Naoufal El Hachlafi; Meryem El Jemly; Maryam Hakkour; Abdelaali Balahbib; Naoual El Menyiy; Saad Bakrim; Hanae Naceiri Mrabti; Aya Khouchlaa; Mohamad Fawzi Mahomoodally; Michelina Catauro; Domenico Montesano; Gokhan Zengin
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

7.  RARRES3 suppressed metastasis through suppression of MTDH to regulate epithelial-mesenchymal transition in colorectal cancer.

Authors:  Zhengting Wang; Liying Wang; Jiajia Hu; Rong Fan; Jie Zhou; Lei Wang; Jie Zhong
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

8.  Long non-coding RNA IQCJ-SCHIP1 antisense RNA 1 is downregulated in colorectal cancer and inhibits cell proliferation.

Authors:  Jia Zhang; Zehua Bian; Guoying Jin; Yuhang Liu; Min Li; Surui Yao; Jing Zhao; Yuyang Feng; Xue Wang; Yuan Yin; Bojian Fei; Xiaofeng Han; Zhaohui Huang
Journal:  Ann Transl Med       Date:  2019-05

Review 9.  Biogenesis, cellular effects, and biomarker value of circHIPK3.

Authors:  Yihan Fu; Hong Sun
Journal:  Cancer Cell Int       Date:  2021-05-11       Impact factor: 5.722

10.  The Clinical Value of the Combined Detection of Enhanced CT, MRI, CEA, and CA199 in the Diagnosis of Rectal Cancer.

Authors:  Cuijuan Hao; Yanbin Sui; Jian Li; Yunxia Shi; Zhenxing Zou
Journal:  J Oncol       Date:  2021-07-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.